Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
13.44B | 10.78B | 4.80B | 1.64B | 8.49B | Gross Profit |
3.88B | 3.04B | 791.10M | -66.90M | 2.45B | EBIT |
2.06B | 1.44B | -339.60M | -839.40M | 1.13B | EBITDA |
3.06B | 2.28B | 325.30M | -467.90M | 1.82B | Net Income Common Stockholders |
1.92B | 1.31B | -240.80M | -1.02B | 648.70M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.11B | 4.66B | 3.12B | 3.77B | 3.16B | Total Assets |
17.18B | 16.41B | 12.33B | 14.75B | 13.25B | Total Debt |
2.75B | 4.12B | 5.43B | 4.21B | 3.64B | Net Debt |
-1.13B | 516.90M | 2.78B | 1.64B | 1.97B | Total Liabilities |
9.56B | 10.76B | 7.68B | 9.78B | 8.04B | Stockholders Equity |
7.61B | 5.64B | 4.65B | 4.97B | 5.21B |
Cash Flow | Free Cash Flow | |||
766.00M | 1.98B | -2.74B | 910.50M | 423.20M | Operating Cash Flow |
3.16B | 3.89B | -2.45B | 2.11B | 2.06B | Investing Cash Flow |
-1.56B | -1.90B | 937.10M | -918.10M | -1.02B | Financing Cash Flow |
-1.33B | -1.05B | 1.62B | -297.40M | -883.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $22.80B | 13.45 | 21.21% | 1.78% | 5.39% | -15.92% | |
74 Outperform | $26.69B | 7.25 | 27.52% | 1.31% | 4.91% | -27.21% | |
74 Outperform | $21.53B | 6.97 | 33.57% | ― | 5.31% | 35.95% | |
70 Outperform | $10.25B | 21.71 | 42.32% | 3.56% | -2.03% | -11.39% | |
63 Neutral | $4.23B | 11.54 | 5.34% | 209.77% | 4.14% | -9.49% | |
61 Neutral | $15.19B | 31.65 | 5.63% | 2.64% | 3.26% | 27.77% | |
58 Neutral | $6.56B | 11.49 | -21.27% | ― | 1.92% | 36.07% |